Lena Hagman
Directeur des opérations chez XVIVO PERFUSION AB
Fortune : 69 060 $ au 30/04/2024
Postes actifs de Lena Hagman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XVIVO PERFUSION AB | Directeur des opérations | 01/12/2022 | - |
Historique de carrière de Lena Hagman
Anciens postes connus de Lena Hagman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GETINGE AB | Compliance Officer | 01/01/2010 | 01/10/2020 |
| Conseiller Juridique Général | 01/01/2010 | 06/10/2022 | |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Directeur des opérations | - | - |
Formation de Lena Hagman
| Chalmers University of Technology | Undergraduate Degree |
Statistiques
Internationale
| Suède | 5 |
Opérationnelle
| Chief Operating Officer | 2 |
| Compliance Officer | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GETINGE AB | Health Technology |
| XVIVO PERFUSION AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Health Technology |
- Bourse
- Insiders
- Lena Hagman
- Expérience
